JohnsonP.C., BertramT.A., TawilB., and HellmanK.B.Hurdles in tissue engineering/regenerative medicine product commercialization: a survey of North American academia and industry. Tissue Eng, Part A, 17, 5, 2011.
2.
MasonC., and ManzottiE.Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regen Med, 5, 307, 2010
3.
VilligerR., and BogdanB.Dissecting monoclonal antibodies mega-deals. mABS, 1, 172, 2009.
4.
VertèsA.A.Time to engage with stem-cell therapeutics. Med Nous April 27th, 20, 2012.
